Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Anxiety Disorders

Clinical Trial Details

Overview

Research Study Summary

A Phase 4 clinical study for patients with Generalized Anxiety Disorder

Research Study Title

Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder: a Multi-center, Randomized, Usual Dose-controlled Trial

Purpose

The purpose of this study is to evaluate the efficacy and safety of comparative high dose Tandospirone Citrate in the treatment of patients with generalized anxiety disorder.

To Learn more
Phase

4

Gender

Both Male and Female

Age

18 to 65 Years

Overall Status

Recruiting

Lead Sponsor

Sumitomo Pharmaceutical (Suzhou) Co., Ltd.

Duration

26 Months

Facility Type

N/A

Eligibility

Both Male and Female ages 18 Years to 65 Years

Inclusion Criteria:

  • 18-65 years old

  • Male or female

  • Diagnosed with GAD according to DSM-IV

  • HAMA score≥17

  • Provide with written informed consent

  • Agree to be washed-out for two weeks if receiving SSRI, SNRI or NASA.

Exclusion Criteria:

  • Serious suicidal tendency

  • The score of the sixth item of HAMA ≥3

  • The score of HAMD ≥21

  • Pregnant or lactating women

  • History of allergic or hypersensitivity to tandospirone

  • Serious or unstable cardiac, renal, neurologic, cerebrovascular, metabolic, or pulmonary disease

  • Secondary anxiety disorders

  • Drug or alcohol dependence within 1 year

  • Patients currently taking benzodiazepine drugs

  • Drivers and dangerous machine operators

  • Participated in other clinical studies in the last 30 days

  • Patients with clinically significant ECG or laboratory abnormalities

  • Patients with a history of epilepsy

  • Patients with abnormal TSH concentration

Site Locations (1)

Country State City Zip Facility and Contact
China Shanghai 200065 Shanghai Tongji Hospital
Wenyuan Wu, MD

Contact

Wenyuan Wu, MD
86-21-66111487
E-mail:

NCT ID: NCT01614041

Date Last Changed: February 19, 2013

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials. Some study summaries have been edited for clarity purposes to make them easier to understand. View more study details here.